Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04317534
Title Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cm
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Greg Durm, MD
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Moffit Cancer Center RECRUITING Tampa Florida 33612 United States Details
University of Illinois Cancer Center RECRUITING Chicago Illinois 60612 United States Details
Indiana University Melvin and Bren Simon Cancer Center RECRUITING Indianapolis Indiana 46202 United States Details
University of Iowa Hospitals and Clinics RECRUITING Iowa City Iowa 52242 United States Details
University of Minnesota RECRUITING Minneapolis Minnesota 55455 United States Details
University of Nebraska Medical Center RECRUITING Omaha Nebraska 68198 United States Details
Rutgers Cancer Institute of New Jersey RECRUITING New Brunswick New Jersey 08903 United States Details
Ohio State University Comprehensive Cancer Center RECRUITING Columbus Ohio 43210 United States Details
Providence Health & Services - Oregon RECRUITING Portland Oregon 97213 United States Details
Penn State Cancer Institute RECRUITING Hershey Pennsylvania 17033 United States Details
University of Virginia Health System RECRUITING Charlottesville Virginia 22908 United States Details
Virginia Commonwealth University RECRUITING Richmond Virginia 23298 United States Details
Univeristy of Wisconsin RECRUITING Madison Wisconsin 53705 United States Details
*Shaded cells indicate that there was no data available from for the field